Notification for retail price fixation of new drug for 80 application
Fixes retail prices of eighty formulations of various pharmaceutical drugs as per the Drugs (Prices Control) Order, 2013.
115 gazette notifications — Page 3 of 3
Fixes retail prices of eighty formulations of various pharmaceutical drugs as per the Drugs (Prices Control) Order, 2013.
Fixes ceiling prices for scheduled drug formulations based on annual Wholesale Price Index increase, effective April 1, 2025.
Fixes ceiling prices for scheduled formulations based on annual Wholesale Price Index increase as per the Drugs (Prices Control) Order, 2013.
Revises ceiling prices for Ringer Lactate injection formulations, effective April 1, 2025, based on a 1.74028% increase in the Wholesale Price Index.
Revises ceiling prices of Piperacillin and Tazobactam injections based on Wholesale Price Index increase, effective April 1, 2025, superseding previous order S.O. No. 1554(E) dated 26.03.2024.
Revises ceiling prices of coronary stents effective April 1, 2025, based on a 1.74028% wholesale price index adjustment for 2024.
Amends the enforcement date of the p-Xylene (Quality Control) Order, 2021 to December 19, 2025.
Amends the Ethylene Dichloride (Quality Control) Order, 2021, changing the enforcement date to September 12, 2025.
Amends enforcement date of Quality Control Orders for Beta Picoline, Sodium Tripolyphosphate, and Pyridine to March 13, 2026.
Fixes retail prices for various scheduled pharmaceutical formulations under the Drugs (Prices Control) Order, 2013.
Corrects dosage form and strength of Azithromycin in Hindi version of Notification S.O. 659(E) regarding ceiling price revision.
Fixes the retail price of Cilnidipine & Telmisartan Tablets manufactured by M/s Akums Drugs & Pharmaceuticals Ltd. and M/s Glenmark Pharmaceuticals Limited.
Fixes the retail price, excluding GST, of forty-two listed pharmaceutical formulations, exercising powers under the Drugs (Prices Control) Order, 2013.
Fixes/revises ceiling prices for scheduled formulations Azithromycin and Amoxicillin + Clavulanic acid under Drugs (Prices Control) Order, 2013, effective from notification date.
This corrigendum revises the ceiling price of Synchrobreathe Inhaler, as previously notified under S.O. 5496(E) dated 19.12.2024.